drugset / Trial / NCT05880888

Investigating the Clinical Impact of a Novel Adipose Allograft Matrix on Knee Fat Pad Impingement Treatment

NCT05880888 ↗

Phase 1 Completed 3 enrolled Ohio State University
NaSingle-groupOpen-labelTreatment

Summary

This study is to assess the effect of Renuva® on fat pad regeneration in patients with Fat pad Impingement

Timeline

Start
2023-04-22
Primary completion
2024-01-09
Completion
2025-02-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Renuva Other / unclassified 3 ml Other

Indications

No indication recorded.